CoChat

Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity

Open access

Published version of a preprint

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Abstract

Tumors with mutant RAS are often dependent on extracellular signal–regulated kinase (ERK) signaling for growth; however, MEK inhibitors have only marginal antitumor activity in these tumors. MEK inhibitors relieve ERK-dependent feedback inhibition of RAF and cause induction of MEK phosphorylation. We have now identified a MEK inhibitor, CH5126766 (RO5126766), that has the unique property of inhibiting RAF kinase as well. CH5126766 binding causes MEK to adopt a conformation in which it cannot be phosphorylated by and released from RAF. This results in formation of a stable MEK/RAF complex and inhibition of RAF kinase. Consistent with this mechanism, this drug does not induce MEK phosphorylation. CH5126766 inhibits ERK signaling output more effectively than a standard MEK inhibitor that induces MEK phosphorylation and has potent antitumor activity as well. These results suggest that relief of RAF feedback limits pathway inhibition by standard MEK inhibitors. CH5126766 represents a new type of MEK inhibitor that causes MEK to become a dominant-negative inhibitor of RAF and that, in doing so, may have enhanced therapeutic activity in ERK-dependent tumors with mutant RAS. Cancer Res; 73(13); 4050–60. ©2013 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-12-3937

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Cited by

See all 194

Metadata

Authors
Ishii, N., Harada, N., Joseph, E. W., Ohara, K., Miura, T., Sakamoto, H., Matsuda, Y., Tomii, Y., Tachibana-Kondo, Y., Iikura, H., Aoki, T., Shimma, N., Arisawa, M., Sowa, Y., Poulikakos, P. I., Rosen, N., Aoki, Y., & Sakai, T.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Corresponding author
  • Rosen, Neal
  • Aoki, Yuko
  • Sakai, Toshiyuki
Venue
Cancer Research
Published
2013-06-30
Volume
73
Issue
13
Pages
4050-4060
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2112463549
Cited by
179
References
35
Citations by year
2026: 18 · 2025: 17 · 2024: 15 · 2023: 6 · 2022: 9 · 2021: 21 · 2020: 9 · 2019: 18 · 2018: 11 · 2017: 7 · 2016: 6 · 2015: 18 · 2014: 18 · 2013: 5
FWCI
7.61
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Cancer Research Institute
  • Chugai Pharmaceutical
  • National Cancer Institute (P01CA129243, T32CA062948)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
MEK inhibitors, allosteric inhibition, Raf kinase, ERK signaling, RAS mutations, MEK phosphorylation, dominant negative inhibition, anticancer activity
MeSH terms
Allosteric Regulation, Animals, Antineoplastic Agents, Coumarins, Enzyme Activation, Female, Humans, Mice, Inbred BALB C, Mice, Nude, Phosphorylation, Protein Binding, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Proto-Oncogene Proteins p21(ras), ras Proteins, Proto-Oncogene Proteins c-raf, MAP Kinase Signaling System, Xenograft Model Antitumor Assays, Feedback, Physiological, Cell Line, Tumor, Extracellular Signal-Regulated MAP Kinases, MAP Kinase Kinase 1, Proto-Oncogene Proteins B-raf, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity. https://app.cochat.ai/papers/10.1158/0008-5472.can-12-3937
The paper
Ishii, N., Harada, N., Joseph, E. W., Ohara, K., Miura, T., Sakamoto, H., Matsuda, Y., Tomii, Y., Tachibana-Kondo, Y., Iikura, H., Aoki, T., Shimma, N., Arisawa, M., Sowa, Y., Poulikakos, P. I., Rosen, N., Aoki, Y., & Sakai, T. (2013). Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity. Cancer Research. https://doi.org/10.1158/0008-5472.can-12-3937

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.